Discover the projected growth and lucrative markets in the global pharmaceutical industry, with a focus on oncology and other therapeutic areas, per Statista.

Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global ...

Q4 2024 Management View CEO Mark Newcomer highlighted that Paysign achieved exceptional growth in its patient affordability business in 2024, with annual revenue increasing by 212% to $12.7 million.

LONDON, March 20 (Reuters) - The pharmaceutical industry on Thursday blasted the ... is forcing them to pay between a quarter and a third of revenues from drug sales in the country back to the ...

Vertex Pharmaceuticals boasts multiple growth avenues. Amgen could tap into more growth opportunities by entering the GLP-1 market. Prosper Junior Bakiny (Eli Lilly): What's considered excellent ...

Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced ...

Analysts have recently evaluated Ultragenyx Pharmaceutical and provided 12-month price targets. The average target is $104.8, ...

The global pharmaceuticals market is estimated to reach $1.21 trillion in 2025, according to Statista data. Overall, Statista predicted the worldwide pharma industry market revenue will increase 4 ...

The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...